Analyze Diet
Equine veterinary journal2025; 58(2); 444-457; doi: 10.1111/evj.70124

Chronic hepatitis in horses with persistent equine hepacivirus infection.

Abstract: Equine hepacivirus (EqHV) is closely related to hepatitis C virus (HCV), which causes persistent infection and chronic hepatitis in people. Information on persistent EqHV infection and hepatitis is limited. Objective: To report 19 cases of chronic hepatitis and persistent EqHV infection. Methods: Mixed retrospective and prospective case series. Methods: Inclusion criteria were: (1) chronic hepatitis, defined as persistently increased serum liver biomarkers, increased serum liver biomarkers accompanied by histopathological evidence of chronicity, for example, fibrosis, or both; (2) positive serum or liver EqHV RT-qPCR; and (3) available liver histopathology. Horses were excluded if they became serum EqHV RT-qPCR undetectable, died, or were euthanised within 6 months of EqHV detection. Liver biopsies were independently reviewed. Results: Twenty-nine horses met inclusion criteria. Ten were subsequently excluded (two cleared EqHV, 8 died within 6 months). For the remaining 19 horses, the median duration of documented hepatitis was 18.4 (range, 5.2-120) months and documented EqHV viremia was 14.8 (range, 6.9-55.6) months. Histopathological findings mirrored those seen in humans with chronic HCV including fibrosis, lymphocytic infiltrate, lymphoid aggregates, and individual hepatocyte necrosis. One horse was diagnosed with bacterial cholangiohepatitis, and the remainder had no definitive etiologic diagnosis. Bacterial infection, equine parvovirus-hepatitis infection, and equine multinodular pulmonary fibrosis were frequent comorbidities. Conclusions: A direct causal link between EqHV viremia and hepatitis cannot be made from these data. Conclusions: Some horses with persistent EqHV infection develop chronic hepatitis and liver failure, with clinical and histopathological findings resembling HCV in humans.
Publication Date: 2025-12-25 PubMed ID: 41448947PubMed Central: PMC12892389DOI: 10.1111/evj.70124Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Cite This Article

APA
Jager MC, Luethy D, Shallop S, Cathcart J, Divers TJ, Tan JY, Beasley EM, Johnson P, Leduc L, Smith C, Jamieson CA, Magdesian KG, Van de Walle GR, Tomlinson JE. (2025). Chronic hepatitis in horses with persistent equine hepacivirus infection. Equine Vet J, 58(2), 444-457. https://doi.org/10.1111/evj.70124

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 58
Issue: 2
Pages: 444-457

Researcher Affiliations

Jager, Mason C
  • Department of Population Medicine and Diagnostic Sciences, Cornell University College of Veterinary Medicine, Ithaca, New York, USA.
Luethy, Daniela
  • Department of Clinical Studies, New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA.
Shallop, Samantha
  • Department of Population Medicine and Diagnostic Sciences, Cornell University College of Veterinary Medicine, Ithaca, New York, USA.
Cathcart, Jessica
  • Department of Clinical Studies, New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA.
Divers, Thomas J
  • Department of Clinical Sciences, Cornell University College of Veterinary Medicine, Ithaca, New York, USA.
Tan, Jean-Yin
  • Faculty of Veterinary Medicine and Taylor Institute for Teaching and Learning, University of Calgary, Calgary, Alberta, Canada.
Beasley, Erin McConachie
  • University of Georgia College of Veterinary Medicine, Athens, Georgia, USA.
Johnson, Philip
  • Equine Internal Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, USA.
Leduc, Laurence
  • Faculté de médecine vétérinaire, Université de Montréal, Saint Hyacinthe, Quebec, Canada.
Smith, Claire
  • Sound Equine Veterinary Hospital, Pouslbo, Washington, USA.
Jamieson, Camilla Anne
  • Department of Veterinary Clinical Sciences, Purdue University College of Veterinary Medicine, West Lafayette, Indiana, USA.
Magdesian, K Gary
  • Department of Medicine and Epidemiology, UC Davis School of Veterinary Medicine, Davis, California, USA.
Van de Walle, Gerlinde R
  • Baker Institute for Animal Health, Cornell University College of Veterinary Medicine, Ithaca, New York, USA.
Tomlinson, Joy E
  • Baker Institute for Animal Health, Cornell University College of Veterinary Medicine, Ithaca, New York, USA.

MeSH Terms

  • Animals
  • Horses
  • Horse Diseases / virology
  • Horse Diseases / pathology
  • Male
  • Hepacivirus / isolation & purification
  • Female
  • Retrospective Studies
  • Prospective Studies
  • Hepatitis C, Chronic / veterinary
  • Hepatitis C, Chronic / virology
  • Hepatitis C, Chronic / pathology
  • Hepatitis, Chronic / veterinary
  • Hepatitis, Chronic / virology
  • Hepatitis, Chronic / pathology

Grant Funding

  • 2022-67015-36343 / National Institute of Food and Agriculture
  • K08AI141767 / National Institute of Allergy and Infectious Diseases
  • K08AI63401 / National Institute of Allergy and Infectious Diseases
  • T32ODO011000 / NIH HHS
  • K08 AI141767 / NIAID NIH HHS
  • K08 AI163401 / NIAID NIH HHS
  • T32 OD011000 / NIH HHS

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 40 references
  1. Gather T, Walter S, Pfaender S, Todt D, Feige K, Steinmann E, et al. Acute and chronic infections with nonprimate hepacivirus in young horses. Vet Res. 2016;47(1):97.
    pmc: PMC5034468pubmed: 27659317
  2. Tomlinson JE, Wolfisberg R, Fahnøe U, Patel RS, Trivedi S, Kumar A, et al. Pathogenesis, microRNA‐122 gene‐regulation, and protective immune responses after acute equine hepacivirus infection. Hepatology. 2021;74(3):1148–1163.
    pmc: PMC8435542pubmed: 33713356
  3. Pfaender S, Cavalleri JMV, Walter S, Doerrbecker J, Campana B, Brown RJP, et al. Clinical course of infection and viral tissue tropism of hepatitis C virus‐like nonprimate hepaciviruses in horses. Hepatology. 2015;61(2):447–459.
    pubmed: 25212983
  4. Scheel TKH, Kapoor A, Nishiuchi E, Brock KV, Yu Y, Andrus L, et al. Characterization of nonprimate hepacivirus and construction of a functional molecular clone. Proc Natl Acad Sci U S A. 2015;112(7):2192–2197. 10.1073/pnas.1500265112
    doi: 10.1073/pnas.1500265112pmc: PMC4343093pubmed: 25646476google scholar: lookup
  5. Hartlage AS, Cullen JM, Kapoor A. The strange, expanding world of animal hepaciviruses. Annu Rev Virol. 2016;3(1):53–75.
    pmc: PMC5523456pubmed: 27741408
  6. Burbelo PD, Dubovi EJ, Simmonds P, Medina JL, Henriquez JA, Mishra N, et al. Serology‐enabled discovery of genetically diverse hepaciviruses in a new host. J Virol. 2012;86(11):6171–6178.
    pmc: PMC3372197pubmed: 22491452
  7. Pfaender S, Walter S, Grabski E, Todt D, Bruening J, Romero‐brey I, et al. Immune protection against reinfection with nonprimate hepacivirus. Proc Natl Acad Sci. 2017;114(12):E2430–E2439.
    pmc: PMC5373355pubmed: 28275093
  8. Ramsay JD, Evanoff R, Wilkinson TE, Divers TJ, Knowles DP, Mealey RH. Experimental transmission of equine hepacivirus in horses as a model for hepatitis C virus. Hepatology. 2015;61(5):1533–1546.
    pubmed: 25580897
  9. Schuppan D, Krebs A, Bauer M, Hahn EG. Hepatitis C and liver fibrosis. Cell Death Differ. 2003;10:S59–S67.
    pubmed: 12655347
  10. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology. 2002;36(5 I):s21–s29.
    pubmed: 12407573
  11. Date T, Sugiyama M, Lkhagvasuren D, Wakita T, Oyunsuren T, Mizokami M. Prevalence of equine hepacivirus infection in Mongolia. Virus Res. 2020;282(April):197940. 10.1016/j.virusres.2020.197940
  12. Elia G, Lanave G, Lorusso E, Parisi A, Trotta A, Buono R, et al. Equine hepacivirus persistent infection in a horse with chronic wasting. Transbound Emerg Dis. 2017;64(5):1354–1358.
    pubmed: 28707785
  13. Tegtmeyer B, Echelmeyer J, Pfankuche VM, Puff C, Todt D, Fischer N, et al. Chronic equine hepacivirus infection in an adult gelding with severe hepatopathy. Vet Med Sci. 2019;5(3):372–378.
    pmc: PMC6682795pubmed: 31267690
  14. Dhingra S, Ward SC, Thung SN. Liver pathology of hepatitis C, beyond grading and staging of the disease. World J Gastroenterol. 2016;22(4):1357–1366.
    pmc: PMC4721971pubmed: 26819505
  15. Gupta E, Bajpai M, Choudhary A. Hepatitis C virus: screening, diagnosis, and interpretation of laboratory assays. Asian J Transfus Sci. 2014;8:19–25.
    pmc: PMC3943138pubmed: 24678168
  16. Tomlinson JE, Tennant BC, Struzyna A, Mrad D, Browne N, Whelchel D, et al. Viral testing of 10 cases of Theiler's disease and 37 in‐contact horses in the absence of equine biologic product administration: a prospective study (2014‐2018). J Vet Intern Med. 2019;33(1):258–265.
    pmc: PMC6335540pubmed: 30520132
  17. Tomlinson JE, Van de Walle GR. Nasal transmission of equine parvovirus hepatitis. J Vet Intern Med. 2022;36(6):2238–2244.
    pmc: PMC9708389pubmed: 36250682
  18. Jager MC, Choi E, Tomlinson JE, Van de Walle G. Naturally acquired equine parvovirus‐hepatitis is associated with a wide range of hepatic lesions in horses. Vet Pathol. 2023;61(3):442–452.
    pmc: PMC11068485pubmed: 38018088
  19. Batts KP, Ludwig J. An update on terminology and reporting. Am J Surg Pathol. 1995;19(12):1409–1417.
    pubmed: 7503362
  20. nMi H, Gong C, Sulam J, Fertig EJ, Szalay AS, Jaffee EM, et al. Digital pathology analysis quantifies spatial heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 immune markers in triple‐negative breast cancer. Front Physiol. 2020;11:583333 Oct 19. [Internet]. [cited 2025 Jul 28]; Available from: www.frontiersin.orgnn
    pmc: PMC7604437pubmed: 33192595
  21. Vengust M, Jager MC, Zalig V, Cociancich V, Laverack M, Renshaw RW, et al. First report of equine parvovirus‐hepatitis‐associated Theiler's disease in Europe. Equine Vet J. 2020;52(6):841–847.
    pmc: PMC7483838pubmed: 32145096
  22. Tomlinson JE, Jager M, Struzyna A, Laverack M, Fortier LA, Dubovi E, et al. Tropism, pathology, and transmission of equine parvovirus‐hepatitis. Emerg Microbes Infect. 2020;9(1):651–663.
    pmc: PMC7144241pubmed: 32192415
  23. de Albuquerque PPLF, Santos LHS, Antunes D, Caffarena ER, Figueiredo AS. Structural insights into NS5B protein of novel equine hepaciviruses and pegiviruses complexed with polymerase inhibitors. Virus Res. 2020;278:197867.
    pubmed: 31972246
  24. Burt A, Ferrell L, Hubscher S. MacSween's pathology of the liver. 7th ed. Philadelphia, PA: Elsevier; 2018.
  25. Delvescovo B, Tomlinson J, DeNotta S, Hodge E, Bookbinder L, Mohammed HO, et al. Bile acids, direct bilirubin and gamma‐glutamyltransferase as prognostic indicators for horses with liver disease in the eastern United States: 82 cases (1997‐2019). J Equine Vet Sci. 2021;105:103729. 10.1016/j.jevs.2021.103729
    doi: 10.1016/j.jevs.2021.103729pubmed: 34607679google scholar: lookup
  26. Kowdley KV, Knox TA, Kaplan MM. Hepatic copper content is Normal in early primary biliary cirrhosis and primary sclerosing cholangitis. Dig Dis Sci. 1994;39:2416–2420.
    pubmed: 7956610
  27. Stegelmeier BL, Gardner DR, James LF, Molyneux RJ. Pyrrole detection and the pathologic progression of Cynoglossum officinale (houndstongue) poisoning in horses. J Vet Diagn Invest. 1996;8(1):81–90.
    pubmed: 9026086
  28. Caloni F, Cortinovis C. Toxicological effects of aflatoxins in horses. Vet J. 2011;188(3):270–273. 10.1016/j.tvjl.2010.06.002
    doi: 10.1016/j.tvjl.2010.06.002pubmed: 20619706google scholar: lookup
  29. Gömer A, Puff C, Reinecke B, Bracht S, Conze M, Baumgärtner W, et al. Experimental cross‐species infection of donkeys with equine hepacivirus and analysis of host immune signatures. One Health Outlook. 2022;4(1):9.
    pmc: PMC9082851pubmed: 35527255
  30. Fredricks DN, Relman DA. Sequence‐based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev. 1996;9(1):18–33.
    pmc: PMC172879pubmed: 8665474
  31. McGorum BC. Clinicopathological features of equine primary hepatic disease: a review of 50 cases. Vet Rec. 1999;145(5):311–315.
    pubmed: 10466831
  32. Fernández J, Prado V, Trebicka J, Amoros A, Gustot T, Wiest R, et al. Multidrug‐resistant bacterial infections in patients with decompensated cirrhosis and with acute‐on‐chronic liver failure in Europe. J Hepatol. 2019;70(3):398–411.
    pubmed: 30391380
  33. Bajaj JS, O'Leary JG, Reddy KR, Wong F, Olson JC, Subramanian RM, et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American Consortium for the Study of End‐stage Liver Disease (NACSELD) experience. Hepatology. 2012;56(6):2328–2335.
    pmc: PMC3492528pubmed: 22806618
  34. Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: a critical review and practical guidance. World J Hepatol. 2016;8:307–321.
    pmc: PMC4766259pubmed: 26962397
  35. Marrie TJ, Tyrrell GJ, Majumdar SR, Eurich DT. Concurrent infection with hepatitis C virus and Streptococcus pneumoniae. Emerg Infect Dis. 2017;23(7):1118–1123.
    pmc: PMC5512482pubmed: 28628455
  36. Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, Fernandez J, et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology. 2019;156(5):1368–1380.e10.
    pubmed: 30552895
  37. Chebrolu P, Colombo RE, Baer S, Gallaher TR, Atwater S, Kheda M, et al. Bacteremia in hemodialysis patients with hepatitis C. Am J Med Sci. 2015;349(3):217–221.
    pubmed: 25734522
  38. Pusterla N, Magdesian KG, Mapes SM, Zavodovskaya R, Kass PH. Assessment of quantitative polymerase chain reaction for equine herpesvirus‐5 in blood, nasal secretions and bronchoalveolar lavage fluid for the laboratory diagnosis of equine multinodular pulmonary fibrosis. Equine Vet J. 2017;49(1):34–38.
    pubmed: 26639080
  39. nPacchiarotti G, Nardini R, Scicluna MT. Equine hepacivirus: a systematic review and a meta‐analysis of serological and biomolecular prevalence and a phylogenetic update. Animals. 2022;12:2486 [Internet]. 2022 Sep 20 [cited 2024 Aug 7];12(19):2486. Available from: https://www.mdpi.com/2076-2615/12/19/2486/htmnn
    pmc: PMC9558973pubmed: 36230228
  40. Divers TJ, Tennant BC, Kumar A, McDonough S, Cullen JM, Bhuva N, et al. A new parvovirus associated with serum hepatitis in horses following inoculation of a common equine biological. Emerg Infect Dis. 2018;24(2):303–310.
    pmc: PMC5782890pubmed: 29350162

Citations

This article has been cited 0 times.